Literature DB >> 2435817

Migrating keratinocytes express urokinase-type plasminogen activator.

S Morioka, G S Lazarus, J L Baird, P J Jensen.   

Abstract

When confluent keratinocyte cultures were wounded by cutting with a blade, the cells rapidly retracted from the wounded site, leaving an area denuded of cells. Within 3-4 h of wounding, keratinocytes began to migrate from the edges and gradually reepithelialized the entire denuded area. Mitomycin C did not prevent the reepithelialization but did dramatically inhibit [3H]thymidine incorporation into the leading edge of cells. These results indicate that cell proliferation was not required for reepithelialization. Using a rabbit antibody against urokinase-type plasminogen activator (u-PA) and an avidin-biotin-peroxidase detection method, we localized u-PA in the keratinocytes at the leading edge of the migrating cultures. Cytochalasin B dramatically inhibited the extent of migration and also altered cell morphology; nonetheless, urokinase was detected in the limited number of cells that moved into the wounded area, even in the presence of cytochalasin B. A small but consistent enhancement (36% +/- 9) of plasminogen activator activity was observed in the supernatant of wounded cultures. These data suggest that plasminogen activator may be involved in the migration of keratinocytes that occurs during wound healing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435817     DOI: 10.1111/1523-1747.ep12469754

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Migration of keratinocytes through tunnels of digested fibrin.

Authors:  V Ronfard; Y Barrandon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Role of plasminogen activator in pemphigus vulgaris.

Authors:  J E Wilkinson; C A Smith; M M Suter; W Falchek; R M Lewis
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

3.  Facilitated wound healing by activation of the Transglutaminase 1 gene.

Authors:  R Inada; M Matsuki; K Yamada; Y Morishima; S C Shen; N Kuramoto; H Yasuno; K Takahashi; Y Miyachi; K Yamanishi
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.

Authors:  P Rørth; C Nerlov; F Blasi; M Johnsen
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

5.  Differential expression of SKALP/Elafin in human epidermal tumors.

Authors:  H A Alkemade; H O Molhuizen; I M van Vlijmen-Willems; U J van Haelst; J Schalkwijk
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

6.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  The kidney is a major site of alpha(2)-antiplasmin production.

Authors:  P A Menoud; N Sappino; M Boudal-Khoshbeen; J D Vassalli; A P Sappino
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation.

Authors:  T J Raife; D J Lager; K C Madison; W W Piette; E J Howard; M T Sturm; Y Chen; S R Lentz
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Genetic Basis of Irritant Susceptibility in Health Care Workers.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; M Michael Barmada; Victor J Johnson; Michael L Kashon; Elma Baron; Nevin W Wilson; Bonnie Frye; Wei Wang; Kara Fluharty; Rola Gharib; Jean Meade; Dori Germolec; Michael I Luster; Susan Nedorost
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

10.  Differential protease expression by cutaneous squamous and basal cell carcinomas.

Authors:  A P Sappino; D Belin; J Huarte; S Hirschel-Scholz; J H Saurat; J D Vassalli
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.